Conference Coverage: ESMO 2023 – Focus on Bladder Cancer

Bladder cancer-specific discussions on therapeutic advances and their application in clinical decision-making

October 24, 2023

Faculty Chair

Daniel Petrylak, MD

Yale University, New Haven, CT, USA


Petros Grivas, MD, PhD
University of Washington, Seattle, WA, USA

Bradley McGregor, MD

Dana-Farber Cancer Institute, Boston, MA, USA

Joaquim Bellmunt, MD, PhD
Dana-Farber Cancer Institute, Boston, MA, USA

Begoña Pérez-Valderrama, MD
Hospital Universitario Virgen del Rocío, Sevilla, Spain

Andrea Necchi, MD
IRCCS San Raffaele Hospital and Scientific Institute, Milan, Italy

José Pablo Maroto-Rey, MD, PhD
Hospital de la Santa Creu i Sant Pau, Barcelona, Spain

Yohann Loriot, MD, PhD
Gustave Roussy Cancer Campus Grand Paris, France

Sample Report

Start discovering the insights

View Report


  • High-Risk BCG-Resistant Nonmuscle-Invasive Bladder Cancer (NMIBC)
  • Muscle-Invasive Bladder Cancer (MIBC)
  • Current Paradigms and Future Directions in Metastatic Bladder Cancer
  • Maintenance Therapy in Metastatic Bladder Cancer

Purchase Report

Thank you for your interest in our insights.

Complete the form below to receive additional information.